OTCMKTS:TKBIF Takara Bio (TKBIF) Stock Price, News & Analysis → “The Stock Market’s Bull Run is Far from Over” -Barrons (From Vertical Research Advisory) (Ad) Free TKBIF Stock Alerts $23.20 0.00 (0.00%) (As of 01/3/2023) Add Compare Share Share Today's Range$23.20▼$23.2050-Day Range$23.20▼$23.2052-Week Range$23.20▼$23.20VolumeN/AAverage Volume100 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Takara Bio alerts: Email Address Ad Vertical Research Advisory“The Stock Market’s Bull Run is Far from Over” -BarronsBarron's reports that the "stock market's bull run is FAR from over…" And recent economic growth will fuel the price of select stocks in the coming months!Click here for all the details now… About Takara Bio Stock (OTCMKTS:TKBIF)Takara Bio Inc., together with its subsidiaries, engages in bioindustry, contract development and manufacturing organization (CDMO), and gene therapy businesses in Japan, China, rest of Asia, the United States, Europe, and internationally. The company sells reagents and instruments, including genetic research reagents and testing kits; products related to coronavirus testing comprising in vitro diagnostics that detect viruses; analytical reagents; single-cell analysis systems; gene expression research reagents; fluorescent proteins series; genome-editing research reagents; iPS cell research reagents; and products for stem cell culturing and induction of differentiation under the TaKaRa, Clontech, and Cellartis brand names. It also provides contract services for regenerative medicine products, such as manufacturing of viral vectors and gene-transduced cells, quality and safety testing, and cell banking; and contract services for gene analysis and testing, including sequencing, intestinal flora analysis, comprehensive analysis of cancer-associated genes, and cell line creation through genome editing. In addition, the company is involved in developing platform technology for biologics development in areas, such as gene therapy. The company was incorporated in 2002 and is based in Kusatsu, Japan. Takara Bio Inc. is a subsidiary of Takara Holdings Inc.Read More TKBIF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TKBIF Stock News HeadlinesFebruary 8, 2024 | morningstar.comTakara Bio Inc TKBIFFebruary 5, 2024 | finance.yahoo.comTakara Bio’s First-to-Market Large-Scale Single-Cell NGS Profiling Technologies Poised to Revolutionize Biomarker DiscoveryMarch 29, 2024 | Vertical Research Advisory (Ad)“The Stock Market’s Bull Run is Far from Over” -BarronsBarron's reports that the "stock market's bull run is FAR from over…" And recent economic growth will fuel the price of select stocks in the coming months!December 11, 2023 | finance.yahoo.comTakara Bio USA Wins EU Opposition Hearing, Revoking Jumpcode Genomics’ NGS Library Enrichment PatentNovember 22, 2023 | wsj.comTakara Bio Inc.October 21, 2022 | investing.comTakara Bio Inc (4974)October 17, 2022 | finance.yahoo.comTakara Bio USA, Inc. and BioExcel Diagnostics Partner for Development of Wide-Coverage Infectious Disease Detection PanelsAugust 5, 2022 | markets.businessinsider.comTAKARA BIO earnings preview: what to expectMarch 29, 2024 | Vertical Research Advisory (Ad)“The Stock Market’s Bull Run is Far from Over” -BarronsBarron's reports that the "stock market's bull run is FAR from over…" And recent economic growth will fuel the price of select stocks in the coming months!November 9, 2021 | markets.businessinsider.comHere's what Wall Street expects from TAKARA BIO's earningsOctober 18, 2021 | finance.yahoo.comTakara Bio USA, Inc. Launches Automated, Full-Length Single-Cell RNA-seq Solution for Enhanced Biomarker DiscoveryJuly 25, 2021 | finance.yahoo.comTAKARA BIO INC (TKBIF) stock forecast and price targetSee More Headlines Receive TKBIF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Takara Bio and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolOTCMKTS:TKBIF CUSIPN/A CIKN/A Webwww.takara-bio.com Phone81 77 565 6920FaxN/AEmployees1,539Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Koichi Nakao (Age 60)CEO, Pres & Representative Director Dr. Yoh Hamaoka Ph.D.Sr. Exec. Officer & DirectorMr. Tsuyoshi MiyamuraSr. Exec. Officer & DirectorMr. Junichi Mineno Ph.D.VP, Exec. Officer & DirectorMasanari Kitagawa Ph.D.Exec. OfficerMr. Masanobu Kimura M.S.MS, R.Ph., Exec. Officer & DirectorMutsumi Sano Ph.D.Sr. Exec. OfficerKatsuhiko KusakabeManaging Exec. OfficerMr. Andrew Farmer Ph.d.Head of R&DAkira KoderaExec. OfficerMore ExecutivesKey Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFAdociaOTCMKTS:ADOIFView All Competitors TKBIF Stock Analysis - Frequently Asked Questions How have TKBIF shares performed in 2024? Takara Bio's stock was trading at $23.20 at the start of the year. Since then, TKBIF stock has increased by 0.0% and is now trading at $23.20. View the best growth stocks for 2024 here. Are investors shorting Takara Bio? Takara Bio saw a decrease in short interest in the month of February. As of February 29th, there was short interest totaling 49,300 shares, a decrease of 36.0% from the February 14th total of 77,000 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is presently ∞ days. View Takara Bio's Short Interest. How do I buy shares of Takara Bio? Shares of TKBIF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:TKBIF) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyOnly a fool would buy Nvidia today… Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Takara Bio Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.